09.07.2026 | BNN Quarterly | RCPE Senior Scientist Sarah Zellnitz-Neugebauer discusses her research on inhalation-based drug delivery for tuberculosis, explaining how advanced formulation strategies and particle engineering can enhance therapeutic efficacy, improve patient adherence, and contribute to combating antimicrobial resistance.